drugset / Trial / NCT01913990
Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.
RandomizedParallel-groupOpen-labelTreatment
Summary
For breast cancer patients receiving chemotherapy regimens, the use of a validated emesis (nausea and vomiting) risk calculator will provide superior anti-emetic (nausea and vomiting) control compared with "standard" anti-emetic regimen. The risk calculator has the potential to provide more individualized anti-emetic regimen by decreasing the use of toxic/costly anti-emetics in patients at low risk and possibly more importantly enhancing the appropriate anti-emetic regimen in patients at high risk.
Timeline
- Start
- 2011-09
- Primary completion
- 2017-08
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | — | — |
| Subject | Dexamethasone | Small molecule | — | — |
| Subject | Ondansetron | Other / unclassified | — | — |
Indications
No indication recorded.